Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC34H45Cl3N8O2 |
InChIKeyNSIDWOUFYRQXGJ-UHFFFAOYSA-N |
CAS Registry2268819-76-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diffuse Large B-Cell Lymphoma | Preclinical | US | - | |
Mantle-Cell Lymphoma | Preclinical | US | - | |
Nervous System Diseases | Preclinical | US | - | |
Nervous System Diseases | Preclinical | US | - |